These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18657842)

  • 1. Suboptimal inhibition of protease activity in human immunodeficiency virus type 1: effects on virion morphogenesis and RNA maturation.
    Moore MD; Fu W; Soheilian F; Nagashima K; Ptak RG; Pathak VK; Hu WS
    Virology; 2008 Sep; 379(1):152-60. PubMed ID: 18657842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein.
    Shehu-Xhilaga M; Hill M; Marshall JA; Kappes J; Crowe SM; Mak J
    J Virol; 2002 May; 76(9):4331-40. PubMed ID: 11932399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal of human immunodeficiency virus type 1 (HIV-1) protease inhibitors from preparations of immature HIV-1 virions does not result in an increase in infectivity or the appearance of mature morphology.
    Humphrey RW; Ohagen A; Davis DA; Fukazawa T; Hayashi H; Höglund S; Mitsuya H; Yarchoan R
    Antimicrob Agents Chemother; 1997 May; 41(5):1017-23. PubMed ID: 9145862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perturbing HIV-1 Ribosomal Frameshifting Frequency Reveals a
    Benner BE; Bruce JW; Kentala JR; Murray M; Becker JT; Garcia-Miranda P; Ahlquist P; Butcher SE; Sherer NM
    J Virol; 2022 Jan; 96(1):e0134921. PubMed ID: 34643428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of protease activity restores efficient virion production to a human immunodeficiency virus type 1 nucleocapsid deletion mutant.
    Ott DE; Coren LV; Chertova EN; Gagliardi TD; Nagashima K; Sowder RC; Poon DT; Gorelick RJ
    J Virol; 2003 May; 77(10):5547-56. PubMed ID: 12719547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maturation of human immunodeficiency virus particles assembled from the gag precursor protein requires in situ processing by gag-pol protease.
    Ross EK; Fuerst TR; Orenstein JM; O'Neill T; Martin MA; Venkatesan S
    AIDS Res Hum Retroviruses; 1991 May; 7(5):475-83. PubMed ID: 1873082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conserved cysteines of the human immunodeficiency virus type 1 protease are involved in regulation of polyprotein processing and viral maturation of immature virions.
    Davis DA; Yusa K; Gillim LA; Newcomb FM; Mitsuya H; Yarchoan R
    J Virol; 1999 Feb; 73(2):1156-64. PubMed ID: 9882317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity.
    Shehu-Xhilaga M; Crowe SM; Mak J
    J Virol; 2001 Feb; 75(4):1834-41. PubMed ID: 11160682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between HIV-1 genome RNA dimerization, virion maturation and infectivity.
    Ohishi M; Nakano T; Sakuragi S; Shioda T; Sano K; Sakuragi J
    Nucleic Acids Res; 2011 Apr; 39(8):3404-17. PubMed ID: 21186186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Immunodeficiency Virus Gag and protease: partners in resistance.
    Fun A; Wensing AM; Verheyen J; Nijhuis M
    Retrovirology; 2012 Aug; 9():63. PubMed ID: 22867298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA and Nucleocapsid Are Dispensable for Mature HIV-1 Capsid Assembly.
    Mattei S; Flemming A; Anders-Össwein M; Kräusslich HG; Briggs JA; Müller B
    J Virol; 2015 Oct; 89(19):9739-47. PubMed ID: 26178992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of human immunodeficiency virus type 1 Pr55(Gag) and Pr160(Gag-pol) processing intermediates that accumulate in primary and transformed cells treated with peptidic and nonpeptidic protease inhibitors.
    Speck RR; Flexner C; Tian CJ; Yu XF
    Antimicrob Agents Chemother; 2000 May; 44(5):1397-403. PubMed ID: 10770790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced maturation of human immunodeficiency virus.
    Mattei S; Anders M; Konvalinka J; Kräusslich HG; Briggs JA; Müller B
    J Virol; 2014 Dec; 88(23):13722-31. PubMed ID: 25231305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring HIV-1 Maturation: A New Frontier in Antiviral Development.
    McGraw A; Hillmer G; Medehincu SM; Hikichi Y; Gagliardi S; Narayan K; Tibebe H; Marquez D; Mei Bose L; Keating A; Izumi C; Peese K; Joshi S; Krystal M; DeCicco-Skinner KL; Freed EO; Sardo L; Izumi T
    Viruses; 2024 Sep; 16(9):. PubMed ID: 39339899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis of HIV-1 maturation using cryo-electron tomography.
    de Marco A; Müller B; Glass B; Riches JD; Kräusslich HG; Briggs JA
    PLoS Pathog; 2010 Nov; 6(11):e1001215. PubMed ID: 21151640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation.
    Shehu-Xhilaga M; Kraeusslich HG; Pettit S; Swanstrom R; Lee JY; Marshall JA; Crowe SM; Mak J
    J Virol; 2001 Oct; 75(19):9156-64. PubMed ID: 11533179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat.
    Fun A; van Maarseveen NM; Pokorná J; Maas RE; Schipper PJ; Konvalinka J; Nijhuis M
    Retrovirology; 2011 Aug; 8():70. PubMed ID: 21864346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.
    Misumi S; Morikawa Y; Tomonaga M; Ohkuma K; Takamune N; Shoji S
    J Biochem; 2004 Mar; 135(3):447-53. PubMed ID: 15113844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcellular Localization of HIV-1
    Becker JT; Sherer NM
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between HIV-1 Gag and Viral RNA Genome Enhance Virion Assembly.
    Dilley KA; Nikolaitchik OA; Galli A; Burdick RC; Levine L; Li K; Rein A; Pathak VK; Hu WS
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28539452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.